ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/09/2024
Voltar para busca
Dado oficial do USPTO
NEXTBIOPHARM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NEXTBIOPHARM
ST13
US500000090106738Classe
9, 35, 38, 42, 44, 45
Pedido
90106738
Registro
6986937
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
05/09/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 38, 42, 44, 45
Data de depósito
11/08/2020
Data de registro
21/02/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/02/2023
Última transação
15/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
17/10/2022
Primeiro uso no comércio
17/10/2022
Código do desenho
4
Tipo de titular
16
Localização do titular
SHANGHAI, CN
Examinador
WLODARCZYK, CAROLYN
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
PHARMCUBE GROUP CO., LTD.
PHARMCUBE (BEIJING) CO., LTD.
Representantes
John R. Hlavka WATTS LAW LLC
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 38Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable electronic datadownloadable electronic data files featuring pharmaceuticalmedicalhealthcarelife science information
Classe 35
Providing clients with business consultingcompetitive product researchclinical data analysismarket analysisproduct line evaluation planning through an online searchable databasebusiness consulting and marketing research and analysis services in the fields of pharmaceuticalsmedicineshealthcare and life science; Conducting market researchdata statistics and information analysis and providing industry research perspectives via an online searchable computer databaseanalyzing and compiling business data and market research in the fields of pharmaceuticalmedicalhealthcarelife science by means of an online searchable computer database for business purposes; Providing an online searchable database providing business intelligence in the fields of pharmaceuticalsmedicineshealthcare and life science
Classe 38
Providing access to databases; Providing electronic transmission of data and documentssending information and images in the nature of telematics sending of information relating to pharmaceuticalsmedicineshealthcare via computer terminals
Classe 42
Implementing early assessment for new drugsproviding an online searchable database featuring information regarding new drugs in the nature of drug discovery services for scientific research purposes; Consulting services in the field of technology developmentconsulting services in the field of technology development in the fields of pharmaceuticalsmedicineshealthcare and life science; Providing search enginesproviding search engines for obtaining data from the internet; Providing an online searchable database featuring information regarding pharmaceuticalsmedicineshealthcare and life science for scientific research purposes; File sharing servicesproviding a website featuring technology enabling users to download electronic files of patent documents
Classe 44
Providing an online searchable database featuring information regarding pharmaceuticalsmedicineshealthcare for medical purposes
Classe 45
Providing information relating to pharmaceutical patentsproviding an online searchable computer database featuring information regarding patents and patent applications in the fields of pharmaceuticalsmedicineshealthcare and life science; Providing patent search servicesproviding an online searchable database featuring information regarding patents and patent applications in the fields of pharmaceuticalsmedicineshealthcare and life science
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
21/02/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
19/01/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/12/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
30/11/2022
EX1G
SOU EXTENSION 1 GRANTED
30/11/2022
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
17/11/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/11/2022
INCE
ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
08/11/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
27/10/2022
IUAF
USE AMENDMENT FILED
18/10/2022
EXT1
SOU EXTENSION 1 FILED
18/10/2022
EEXT
SOU TEAS EXTENSION RECEIVED
18/10/2022
EISU
TEAS STATEMENT OF USE RECEIVED
18/10/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
19/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/02/2022
PUBO
PUBLISHED FOR OPPOSITION
22/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/01/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
17/01/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
18/07/2021
GNFR
FINAL REFUSAL E-MAILED
18/07/2021
CNFR
FINAL REFUSAL WRITTEN
18/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/12/2020
GNRT
NON-FINAL ACTION E-MAILED
05/12/2020
CNRT
NON-FINAL ACTION WRITTEN
05/12/2020
DOCK
ASSIGNED TO EXAMINER
04/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2020
NWAP
NEW APPLICATION ENTERED
14/08/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEXTBIOPHARM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.